Article Details
Retrieved on: 2021-04-14 19:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The primary endpoint was biochemical relapse-free survival (bRFS). Risk groups were based on prostate-specific antigen (PSA) ≥ 0.8 ng/mL and ...
Article found on: www.docwirenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here